- Favorable safety profile with no treatment-related serious adverse events - ...

CLN-049 monotherapy demonstrates promising efficacy, including multiple complete responses and encouraging response ...

More often, though, the discourse mines the sport’s one truly inexhaustible resource: Chaos. The only thing that has changed ...

Brain Canada is proud to partner with Dalhousie University and the Nova Scotia Department of Education and Early Childhood Development to bring the Neuroscience Roadshow project to high schools across ...

Rocket Doctor AI joins forces with the CAN Health Network to deliver an AI-powered Clinical Decision Support System (CDSS) in collaboration with ...

AV, with partner Parry Labs, has been awarded a 3-year Other Transaction Agreement with an initial base contract value of $13.2M with additional options for a total potential contract value of $42M to ...

Co., Ltd., stated: "As a proud member of the interpack global alliance, since its launch in 2015, swop has carried the mission of advancing China's packaging industry. From that original blueprint to ...

A combination of two therapies, azacitidine and venetoclax, or aza-ven, outperformed intensive chemotherapy for acute myeloid leukemia in patients healthy enough to receive aggressive treatment, ...

Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States ...

The FIDO Alliance is tightening how relying parties evaluate passkeys and other FIDO authenticators, rolling out new versions of its Metadata Service (MDS) and a streamlined Convenience Metadata ...

A decade-long investigation of shorter regimens of hypomethylating agents for low-risk myelodysplastic syndrome revealed a ...

Patients with polycythemia vera (PV), a rare cancer characterized by overabundant red blood cells, have endured years of middling progress in their therapeutic options. | Patients with polycythemia ...